Chris Abbosh

Academic Clinical Fellow

University College London

Dr Chris Abbosh is a senior clinical fellow in medical oncology working on the Cancer Research UK funded lung TRACERx (TRAcking lung Cancer Evolution through treatment Rx) study under the supervision of Professor Charles Swanton at University College London. Chris led the construction of the first TRACERx cell free DNA manuscript focusing on minimal residual disease detection in the adjuvant NSCLC setting which was published in the journal Nature. He is particularly interested in application of circulating tumor DNA (ctDNA) as a tool to stratify risk in adjuvant clinical trials.